Damian Green will join Sylvester Comprehensive Cancer Center at the University Miami Miller School of Medicine this spring to lead its transplantation and cellular therapy services. Green was named chief of the Division of Transplantation & Cellular Therapy, as well as assistant director of Translational Research, beginning March 1.
Caroline Germa was named chief medical officer at Ikena Oncology Inc.
The governing body of the Cancer Prevention and Research Institute of Texas, or CPRIT, approved $98,592,155 in grants to focus on cancer in Texas. The grants are a mix of academic research and prevention projects and represents the largest public state commitment to cancer research by any U.S. state.
People in Mercer and Lawrence counties will soon have enhanced access to cancer care as UPMC Hillman Cancer Center at UPMC Horizon-Shenango Valley initiates an expansion to add a second linear accelerator.
Tampa General Hospital was named an approved Center of Excellence facility for pancreatic cancer treatment by the National Pancreas Foundation.
OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences earned a three-year accreditation from the National Accreditation Program for Rectal Cancer, making it the only accredited program in Oklahoma and one of only three other accredited programs within a 500-mile radius to receive the accreditation from the quality program of the American College of Surgeons.
Regeneron Pharmaceuticals Inc. and Society for Science today announced the top 40 finalists in this year’s Regeneron Science Talent Search, the nation’s oldest and most prestigious science and math competition for high school seniors.
Energy and Commerce Committee Health Subcommittee Ranking Member Rep. Anna G. Eshoo (D-CA), Ranking Member Rep. Frank Pallone, Jr. (D-NJ), and Oversight and Investigations Subcommittee Ranking Member Rep. Kathy Castor (D-FL) wrote to FDA Commissioner Robert M. Califf to urge the agency to move forward with guidance to improve the diversity of populations represented in clinical trials.
Jill DeSimone, a global pharmaceutical executive, joined Swim Across America’s board of directors.
Monica L. Baskin, an expert in health equity, was named deputy director of UPMC Hillman Cancer Center.
